Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 13,428 | 14,677 | 13,898 | 14,829 | 15,726 |
| Cost of Goods | 8,861 | 10,397 | 8,868 | 9,256 | 10,350 |
| Gross Profit | 4,567 | 4,280 | 5,030 | 5,573 | 5,376 |
| Operating Expenses | 9,202 | 9,177 | 20,750 | 9,748 | 13,878 |
| Operating Income | -3,774 | -4,500 | -14,852 | -3,919 | -8,152 |
| Interest Expense | 2,292 | 2,387 | 3,823 | 2,551 | 2,028 |
| Other Income | 566 | 389 | 62 | 154 | -244 |
| Pre-tax Income | -5,500 | -6,498 | -18,613 | -6,316 | -10,424 |
| Income Tax | -3 | 222 | -267 | -11 | -14 |
| Net Income Continuous | -5,497 | -6,720 | -18,346 | -6,305 | -10,410 |
| Net Income Discontinuous | -3 | -1 | 12,358 | 496 | 331 |
| Net Income | $-5,500 | $-6,721 | $-5,988 | $-5,809 | $-10,079 |
| EPS Basic Total Ops | -3.59 | -4.40 | -3.91 | -3.81 | -4.88 |
| EPS Basic Continuous Ops | -3.59 | -4.38 | -11.98 | -4.13 | -5.00 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 8.07 | 0.32 | 0.12 |
| EPS Diluted Total Ops | -3.59 | -4.40 | -3.91 | -3.81 | -4.88 |
| EPS Diluted Continuous Ops | -3.59 | -4.38 | -11.98 | -4.13 | -5.00 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 8.07 | 0.32 | 0.12 |
| EPS Diluted Before Non-Recurring Items | -3.40 | -4.50 | -5.00 | N/A | N/A |
| EBITDA(a) | $-3,312 | $-4,271 | $-14,368 | $-3,317 | $-7,484 |